Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.

@article{Mueller2010BodyCA,
  title={Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.},
  author={Andreas Mueller and Hendryk Zollver and Desiree Kronawitter and Patricia G. Oppelt and Tomma Claassen and Inge Hoffmann and Matthias Wilhelm Beckmann and Ralf Dittrich},
  journal={Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association},
  year={2010},
  volume={119 2},
  pages={
          95-100
        }
}
OBJECTIVE In transsexual people, cross-sex hormone therapy is an important component of medical treatment and results in a complete change in the sex hormone environment. Steroid hormones plays an important role in developing and maintaining bone mass and body composition in both sexes. The aim of this study was to evaluate changes in body composition and bone mineral density (BMD) during cross-sex hormone therapy in transsexuals using gonadotrophin-releasing hormone agonists and intramuscular… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During .

  • A Mueller
  • Exp Clin Endocrinol Diabetes
  • 2011

Prevalence of low bone mass in relation to estrogen treatment and body composition in male - to - female transsexual persons

  • S Weyers, Y Taes
  • J Clin Densitom
  • 2009

Similar Papers

Loading similar papers…